Cancer Genetics and Epigenetics 2015, Vol.3, No.13, 1-6
5
Figure 4 The cumulative survival function of screened
methylation site
special Fund for excellent academic leader of Harbin
(grant number 2015RAXYJ051).
References
Baylin S.B., Esteller M., Rountree M.R., Bachman K.E., Schuebel K., and
Herman J.G., 2001, Aberrant patterns of DNA methylation, chromatin
formation and gene expression in cancer, Hum Mol Genet, 10: 687-692
Bird A., 2002, DNA methylation patterns and epigenetic memory, Genes
Dev, 16: 6-21
Bird A.P., 1980, DNA methylation and the frequency of CpG in animal
DNA, Nucleic Acids Res, 8: 1499-1504
Bird A.P., 1986, CpG-rich islands and the function of DNA methylation,
Nature, 321: 209-213
Blum W.F., Horn N., Kratzsch J., Jorgensen J.O., Juul A., Teale D., Mohnike
K., and Ranke M.B., 1993, Clinical studies of IGFBP-2 by
radioimmunoassay, Growth Regul, 3: 100-104
Busund L.T., Richardsen E., Busund R., Ukkonen T., Bjornsen T., Busch C.,
and Stalsberg H., 2005, Significant expression of IGFBP2 in breast
cancer compared with benign lesions, J Clin Pathol, 58: 361-366
Cindolo L., Franco R., Cantile M., Schiavo G., Liguori G., Chiodini P.,
Salzano L., Autorino R., Di Blasi A., Falsaperla M., Feudale E., Botti
G., Gallo A., and Cillo C., 2007, NeuroD1 expression in human
prostate cancer: can it contribute to neuroendocrine differentiation
comprehension?, Eur Urol, 52: 1365-1373
Das P.M., and Singal R., 2004, DNA methylation and cancer, J Clin Oncol,
22: 4632-4642
Egger G., Liang G., Aparicio A., and Jones P.A., 2004, Epigenetics in human
disease and prospects for epigenetic therapy, Nature, 429: 457-463
Ehrlich M., 2002, DNA methylation in cancer: too much, but also too little,
Oncogene, 21: 5400-5413
Esteller M., Corn P.G., Baylin S.B., and Herman J.G., 2001, A gene
hypermethylation profile of human cancer, Cancer Res, 61: 3225-3229
Esteller M., and Herman J.G., 2002, Cancer as an epigenetic disease: DNA
methylation and chromatin alterations in human tumours, J Pathol, 196:
1-7
Fisher M.C., Meyer C., Garber G., and Dealy C.N., 2005, Role of IGFBP2,
IGF-I and IGF-II in regulating long bone growth, Bone, 37: 741-750
Fukushima T., and Kataoka H., 2007, Roles of insulin-like growth factor
binding protein-2 (IGFBP-2) in glioblastoma, Anticancer Res, 27:
3685-3692
Fuller G.N., Rhee C.H., Hess K.R., Caskey L.S., Wang R., Bruner J.M.,
Yung W.K., and Zhang W., 1999, Reactivation of insulin-like growth
factor binding protein 2 expression in glioblastoma multiforme: a
revelation by parallel gene expression profiling, Cancer Res, 59:
4228-4232
Greer E.L., and Shi Y., 2012, Histone methylation: a dynamic mark in health,
disease and inheritance, Nat Rev Genet, 13: 343-357
Heald A.H., Kaushal K., Siddals K.W., Rudenski A.S., Anderson S.G., and
Gibson J.M., 2006, Insulin-like growth factor binding protein-2
(IGFBP-2) is a marker for the metabolic syndrome, Exp Clin
Endocrinol Diabetes, 114: 371-376
Hsieh D., Hsieh A., Stea B., and Ellsworth R., 2010, IGFBP2 promotes
glioma tumor stem cell expansion and survival, Biochem Biophys Res
Commun, 397: 367-372
Hwa V., Oh Y., and Rosenfeld R.G., 1999, The insulin-like growth
factor-binding protein (IGFBP) superfamily, Endocr Rev, 20: 761-787
Jones P.A., 1996, DNA methylation errors and cancer, Cancer Res, 56:
2463-2467
Jones P.A., 2012, Functions of DNA methylation: islands, start sites, gene
bodies and beyond, Nat Rev Genet, 13: 484-492
Jones P.A., and Baylin S.B., 2002, The fundamental role of epigenetic
events in cancer, Nat Rev Genet, 3: 415-428
Jones P.A., and Takai D., 2001, The role of DNA methylation in mammalian
epigenetics, Science, 293: 1068-1070
Jones P.A., and Taylor S.M., 1980, Cellular differentiation, cytidine analogs
and DNAmethylation, Cell, 20: 85-93
Lee J.T., 2012, Epigenetic regulation by long noncoding RNAs, Science,
338: 1435-1439
Li E., 2002, Chromatin modification and epigenetic reprogramming in
mammalian development, Nat Rev Genet, 3: 662-673
Li E., Beard C., Forster A.C., Bestor T.H., and Jaenisch R., 1993a, DNA
methylation, genomic imprinting, and mammalian development, Cold
Spring Harb Symp Quant Biol, 58: 297-305
Li E., Beard C., and Jaenisch R., 1993b, Role for DNA methylation in
genomic imprinting, Nature, 366: 362-365
Lin Y., Jiang T., Zhou K., Xu L., Chen B., Li G., Qiu X., Jiang T., Zhang W.,
and Song S.W., 2009, Plasma IGFBP-2 levels predict clinical outcomes
of patients with high-grade gliomas, Neuro Oncol, 11: 468-476
Menouny M., Binoux M., and Babajko S., 1997, Role of insulin-like growth
factor binding protein-2 and its limited proteolysis in neuroblastoma
cell proliferation: modulation by transforming growth factor-beta and
retinoic acid, Endocrinology, 138: 683-690
Mishra L., Bass B., Ooi B.S., Sidawy A., and Korman L., 1998, Role of
insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding
protein-2 in human colorectal cancers, Growth Horm IGF Res, 8: 473-479
Momparler R.L., and Bovenzi V., 2000, DNA methylation and cancer, J Cell
Physiol, 183: 145-154
Prelle K., Stojkovic M., Boxhammer K., Motlik J., Ewald D., Arnold G.J.,
and Wolf E., 2001, Insulin-like growth factor I (IGF-I) and long
R(3)IGF-I differently affect development and messenger ribonucleic
acid abundance for IGF-binding proteins and type I IGF receptors in in
